00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Nature of Business and Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Sale of Aptevo BioTherapeutics link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Collaboration Agreements link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Cash, Cash Equivalents, and Restricted Cash link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Debt link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Leases link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Reverse Stock Split link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Net Income (Loss) per Share link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Equity link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Nature of Business and Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Sale of Aptevo BioTherapeutics (Tables) link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Cash, Cash Equivalents, and Restricted Cash (Tables) link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Leases (Tables) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Net Income (Loss) per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Equity (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Nature of Business and Significant Accounting Policies - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Sale of Aptevo BioTherapeutics - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Sale of Aptevo BioTherapeutics - Gain of Sale of Business (Details) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Sale of Aptevo BioTherapeutics - Summary of Reconciliation of Carrying Amounts of Assets and Liabilities and Income (Loss) from Discontinued Operation (Details) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Collaboration Agreements - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Fair Value Measurements - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Cash, Cash Equivalents and Restricted Cash - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Cash, Cash Equivalents and Restricted Cash - Schedule of Cash, Cash Equivalents and Long-term Restricted Cash (Details) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Debt - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Leases - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Leases - Components of Lease Expense (Details) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Leases - Summary of Right of Use Assets Acquired Under Operating Leases (Details) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Reverse Stock Split - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Net Income (Loss) Per Share - Computation of Basic and Diluted Net Loss per Share (Details) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Net Income (Loss) Per Share - Summary of Potentially Dilutive Shares Excluded from Calculation of Net Loss Per Share (Details) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Equity - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Equity - Summary of Stock-based Compensation Expense Includes Amortization of Stock Options and Restricted Stock Units Granted (Details) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Equity - Assumptions used in Valuing the Stock Options Granted under Black-Scholes Valuation Model (Details) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Equity - Summary of Stock Option Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Equity - Summary of Restricted Stock Activity (Details) link:calculationLink link:presentationLink link:definitionLink